Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $3.22, but opened at $3.40. Curaleaf shares last traded at $3.27, with a volume of 12,003 shares.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three investment analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Strong Buy”.

Curaleaf Trading Up 0.3%

The stock has a market cap of $2.33 billion, a PE ratio of -25.69 and a beta of 1.58. The stock has a 50-day moving average price of $2.83 and a two-hundred day moving average price of $2.65. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.17. The firm had revenue of $324.23 million during the quarter, compared to the consensus estimate of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. Sell-side analysts forecast that Curaleaf Holdings, Inc. will post -0.12 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.